Director/PDMR Shareholding

RNS Number : 8398B

Epistem Holdings plc

08 April 2013

 



Epistem Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 195 ordinary shares of 1.5p each. These shares were acquired on 28^th January 2013, 25^th February 2013 and 25^th March 2013 at prices of 556p, 554p and 556p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                           10,174                                    0.11%

Dr Catherine Booth                  984,529                                  10.19%

Dr Jeffrey Moore                       13,854                                    0.14%

John Rylands                            194,427                                    2.01%

Epistem further announces that it was informed on 5^th  April 2013 that, on that day, Dr Catherine Booth transferred 8,721 ordinary shares of 1.5 pence each to her Self Invested Personal Pension fund at a price of 550p Following this transaction, Dr. Catherine Booth's beneficial interest remains unchanged at 984,529 ordinary shares representing 10.19% of the Company's issued share capital.

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                               [phone]

Peel Hunt LLP

James Steel /Vijay Barathan                                                     [phone]

 

END

 

 

RDSBUGDSRGGBGXI